EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prophylactic Soraphen A Treatment Attenuates Western Diet‐Exacerbated IMQ‐Induced Psoriasiform Inflammation

Yu-San Kao, Katharina S Kommoss, Tabea Bieler, Gloria Janet Godoy, Aleksandra Lopez Krol, Fatima Boukhallouk, Felix K F Kommoss, Danijela Heide, Susanne H Kirsch, Rolf Müller, Mathias Heikenwälder, Tim Sparwasser

European Journal of Immunology · 2026-10 · 56 (10)

DOI: 10.1002/eji.70298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 27.10.2026. Verfasst von Yu-San Kao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: Diet, Western, Psoriasis, Inflammation. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Physician-Scientist Programme of Heidelberg University, Faculty of Medicine, German Research Foundation, German Centre for Infection Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a T‐cell‐mediated inflammatory disease amplified by metabolic stress. Acetyl‐CoA carboxylase 1 (ACC1)‐dependent fatty acid synthesis is required for IL‐17‐producing T cells. Here, we asked whether short‐term systemic administration of soraphen A (SorA), a dual ACC1/2 inhibitor, modulates imiquimod (IMQ)‐induced psoriasiform inflammation under normal diet (ND) and Western diet (WD) conditions. Female C57BL/6J mice were fed ND or WD for 12 weeks prior to daily intraperitoneal injections of SorA or vehicle for 10 days, followed by 5 days of topical IMQ to induce psoriasiform dermatitis. Disease severity was assessed by macroscopic, histological, transcriptional, and flow cytometric readouts. Prophylactic SorA administration had no measurable effect in ND‐fed mice. In WD‐fed mice, prophylactic SorA reduced erythema, back skin thickening, and epidermal hyperplasia, whereas scaling remained unchanged. Selected histological skin readouts were numerically lower, whereas the qPCR panel showed no statistically significant differences. In skin‐draining lymph nodes, IL‐17A + CD4 + and CD8 + T‐cell frequencies and numbers were significantly reduced, whereas γδT17 cells did not differ significantly. Hepatic steatosis scores were unchanged, but hepatic neutrophil infiltration was reduced. Under the present prophylactic regimen, systemic SorA administration was associated with modest attenuation of WD‐exacerbated IMQ‐induced psoriasiform inflammation. These findings support further preclinical evaluation of ACC‐targeted immunometabolic interventions in metabolically aggravated psoriasiform inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, WesternPsoriasisInflammationAnimalsFemaleMiceImiquimodMice, Inbred C57BLInterleukin-17SkinDisease Models, AnimalAcetyl-CoA CarboxylaseMacrolides

Stichwörter der Autor:innen

acetyl‐CoA carboxylase (ACC) 1fatty acid synthesismetabolic inflammationpsoriasis

Substanzen

Imiquimodsoraphen AInterleukin-17Acetyl-CoA CarboxylaseMacrolides

Autor:innen und Institutionen

  • Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Fachbereich Biologie, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Institute of Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.

Förderung

  • Physician-Scientist Programme of Heidelberg University, Faculty of Medicine
  • German Research Foundation
  • German Centre for Infection Research
  • Federal Ministry of Education and Research (BMBF) and the Ministry of Science Baden-Württemberg
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Kao, Y. S., Kommoss, K. S., Bieler, T., Godoy, G. J., Lopez Krol, A., Boukhallouk, F., Kommoss, F. K. F., Heide, D., Kirsch, S. H., Müller, R., Heikenwälder, M., & Sparwasser, T. (2026). Prophylactic Soraphen A Treatment Attenuates Western Diet‐Exacerbated IMQ‐Induced Psoriasiform Inflammation. European Journal of Immunology, 56(10). https://doi.org/10.1002/eji.70298

Vancouver

Kao YS, Kommoss KS, Bieler T, Godoy GJ, Lopez Krol A, Boukhallouk F, et al. Prophylactic Soraphen A Treatment Attenuates Western Diet‐Exacerbated IMQ‐Induced Psoriasiform Inflammation. European Journal of Immunology. 2026;56(10). doi:10.1002/eji.70298

BibTeX
@article{Kao2026,
  author = {Kao, Yu-San and Kommoss, Katharina S and Bieler, Tabea and Godoy, Gloria Janet and Lopez Krol, Aleksandra and Boukhallouk, Fatima and Kommoss, Felix K F and Heide, Danijela and Kirsch, Susanne H and Müller, Rolf and Heikenwälder, Mathias and Sparwasser, Tim},
  title = {Prophylactic Soraphen A Treatment Attenuates Western Diet‐Exacerbated IMQ‐Induced Psoriasiform Inflammation},
  journal = {European Journal of Immunology},
  year = {2026},
  volume = {56},
  number = {10},
  doi = {10.1002/eji.70298}
}
Kostenlos starten →